...
首页> 外文期刊>Plant Genetic Resources Characterization and Utilization >Sustainable bioproduction of phytochemicals by plant in vitro cultures: anticancer agents.
【24h】

Sustainable bioproduction of phytochemicals by plant in vitro cultures: anticancer agents.

机译:通过植物体外培养实现植物化学物质的可持续生物生产:抗癌药。

获取原文
获取原文并翻译 | 示例

摘要

Due to their complex structure with several chiral centres important anticancer agents are still extracted from plants and not synthesized chemically on a commercial scale. Sustainable bioproduction of the compounds of interest may be achieved by plant in vitro cultures. Undifferentiated callus and suspension cultures, which can be cultivated in large bioreactors easily, very often fail to accumulate the compounds of interest, whereas shoot and root cultures as well hairy roots normally produce the same compounds as in the appropriate organs. The production of anticancer compounds, such as the alkaloids vinblastine, vincristine, paclitaxel (TaxolReg.), camptothecin, or the lignan podophyllotoxin, by plant in vitro cultures is reviewed. Taxanes can be produced in bioreactors using cell suspensions of various Taxus species with good yields; presently paclitaxel is produced on a commercial scale by Phyton Biotech (Germany). Camptothecin has low yields in suspension cultures of Camptotheca acuminata or Nothapodytes foetida (0.0003-0.01%), but a good production (0.1-0.3% dry wt) in root and hairy root cultures of Ophiorrhiza pumila, O. mungos and C. acuminata. Podophyllotoxin can be produced in cell suspension and root as well as hairy root cultures of Podophyllum and various Linum species up to 130 mg/l (Linum album cell suspensions); its derivative 6-methoxypodophyllotoxin is accumulated in hairy roots of L. persicum up to about 500 mg/l. The in vitro production of dimeric indole alkaloids in Catharanthus roseus has failed so far both in undifferentiated and differentiated in vitro cultures. In cases where in vitro cultures show good yields, they can be employed in biotechnology for the sustainable production of valuable products..
机译:由于它们具有几个手性中心的复杂结构,重要的抗癌药仍从植物中提取出来,并且没有以商业规模化学合成。感兴趣的化合物的可持续生物生产可通过植物体外培养来实现。未分化的愈伤组织和悬浮培养物很容易在大型生物反应器中进行培养,但往往无法积聚目标化合物,而枝条和根部培养物以及毛状根通常会产生与适当器官相同的化合物。综述了通过植物体外培养产生的抗癌化合物,例如长春碱,长春新碱,紫杉醇(TaxolReg。),喜树碱或木脂素鬼臼毒素。紫杉烷可以在生物反应器中使用各种紫杉属的细胞悬浮液生产,并具有良好的产量;目前,紫杉醇是由Phyton Biotech(德国)以商业规模生产的。喜树碱在喜树或鬼臼的悬浮培养物中产量较低(0.0003-0.01%),但在Ophiorrhiza pumila,O。mungos和C. acuminata的根和毛状根培养物中,产量较高(干重0.1-0.3%)。鬼臼毒素可以在鬼臼和各种亚麻属物种的细胞悬浮液和根以及毛状根培养物中产生,最高浓度为130 mg / l(林姆专辑细胞悬浮液)。其衍生物6-甲氧基鬼臼毒素累积在百日草的毛状根中,最高约500 mg / l。迄今为止,在未分化和分化的体外培养物中,长春花中的二聚吲哚生物碱的体外生产都失败了。如果体外培养显示出良好的产量,则可将它们用于生物技术中以可持续生产有价值的产品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号